A prospective clinical study of theophylline safety in 3810 elderly with asthma or COPD

Respiratory Medicine

Volumn 98, Issue 10, 2004, Pages 1016-1024

  Ohta, Ken ^a   Fukuchi, Yoshinosuke ^b   Grouse, Lawrence ^c   Mizutani, Ryuji ^d   Rabe, Klaus F ^e   Rennard, Stephen I ^f   Zhong, Nan Shan ^g  

^a TEIKYO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c UNIVERSITY OF WASHINGTON   (United States)

^d MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^e LEIDEN UNIVERSITY   (Netherlands)

^f UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^g GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Adverse event; Bronchial asthma; Chronic obstructive pulmonary disease; Japanese elderly; Theophylline

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; NITROGEN; STEROID; THEOPHYLLINE; UREA;

ABDOMINAL DISTENSION; AGED; ANOREXIA; ARTICLE; ASTHMA; ASTHMATIC STATE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; CORRELATION ANALYSIS; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ELDERLY CARE; ERYTHROPENIA; FEMALE; FREQUENCY ANALYSIS; HEADACHE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART PALPITATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; HYPERURICEMIA; INCIDENCE; INSOMNIA; JAPAN; LEUKOPENIA; LIVER DISEASE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MALLORY WEISS SYNDROME; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; PRURITUS; RISK ASSESSMENT; STOMACH ULCER; SUSTAINED RELEASE FORMULATION; TABLET FORMULATION; TACHYCARDIA; THORAX PAIN; UREA NITROGEN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ASTHMA; BRONCHODILATOR AGENTS; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; THEOPHYLLINE;

EID: 11144329060     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.02.020     Document Type: Article

References (30)

1. Sullivan P. Bekir S. Jaffar Z. Page C. Jeffery P. Costello J. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma Lancet 343 1994 1006-1008
2. Kidney J. Dominguez M. Taylor P.M. Rose M. Chung K.F. Barnes P.J. Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy Am J Respir Crit Care Med 151 1995 1907-1914
3. Ohta K. Yamashita N. Apoptosis of eosinophils and lymphocytes in allergic inflammation J Allergy Clin Immunol 104 1999 14-21
4. Finnerty J.P. Lee C. Wilson S. Madden J. Djukanovic R. Holgate S.T. Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects: A placebo-controlled parallel group study Eur Respir J 9 1996 1672-1677
5. Global Initiative for Asthma Management and Prevention. National Institutes of Health, 2002.
6. Zwillich C.W. Sutton F.D. Neff T.A. Cohn W.M. Matthay R.A. Weinberger M.M. Theophylline-induced seizures in adults. Correlation with serum concentrations Ann Intern Med 82 1975 784-787
7. Randolph W.C. Seaman J.J. Dickson B. Peace K.E. Frank W.O. Young M.D. The effect of age on theophylline clearance in normal subjects Br J Clin Pharmacol 22 1986 603-605
8. Jackson S.H. Johnston A. Woollard R. Turner P. The relationship between theophylline clearance and age in adult life Eur J Clin Pharmacol 36 1989 29-34
9. Ueno K. Uetsuki S. Toda H. Seki T. Kato M. Effect of age on theophylline clearance in a Japanease population Jpn J TDM 14 1997 336-343
10. Vestal R.E. Cusack B.J. Crowley J.J. Loi C.M. Aging and the response to inhibition and induction of theophylline metabolism Exp Gerontol 28 1993 421-433
11. Hary L. Vieile M.H. Lienard J. Andrejak M. Effects of age on theophylline kinetics in hospitalized patients Curr Ther Res 44 1988 110-117
12. Cusack B. Kelly J.G. Lavan J. Noel J. O'Malley K. Theophylline kinetics in relation to age: The importance of smoking Br J Clin Pharmacol 10 1980 109-114
13. Jackson S.H. Wiffen J.K. Johnston A. Peverel-Cooper C.A. The relationship between clearance of theophylline and age within the adult age range Eur J Clin Pharmacol 29 1985 177-179
14. Mangione A. Imhoff T.E. Lee R.V. Shum L.Y. Jusko W.J. Pharmacokinetics of theophylline in hepatic disease Chest 73 1978 616-622
15. Kraan J. Jonkman J.H. Koeter G.H. et al. The pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis and in patients with chronic renal disease Eur J Clin Pharmacol 35 1988 357-362
16. Piafsky K.M. Sitar D.S. Rangno R.E. Ogilvie R.I. Theophylline disposition in patients with hepatic cirrhosis N Engl J Med 296 1977 1495-1497
17. Colli A. Buccino G. Cocciolo M. Parravicini R. Scaltrini G. Disposition of a flow-limited drug (lidocaine) and a metabolic capacity-limited drug (theophylline) in liver cirrhosis Clin Pharmacol Ther 44 1988 642-649
18. Staib A.H. Schuppan D. Lissner R. Zilly W. von Bomhard G. Richter E. Pharmacokinetics and metabolism of theophylline in patients with liver diseases Int J Clin Pharmacol Ther Toxicol 18 1980 500-502
19. Macolic V. Vrhovac B. Pharmacokinetics and interactions of digoxin, theophylline and furosemide in diseases with edema Int J Clin Pharmacol Ther Toxicol 31 1993 6-11
20. Feinstein R.A. Miles M.V. The effects of acute viral hepatitis on theophylline clearance Clin Pediatr 24 1985 357-358
21. Upton R.A. Pharmacokinetic interactions between theophylline and other medication (Part I) Clin Pharmacokinet 20 1991 66-80
22. Upton R.A. Pharmacokinetic interactions between theophylline and other medication (Part II) Clin Pharmacokinet 20 1991 135-150
23. Lee BL, Benowitz NL, Jacob P III. Cigarette abstinence, nicotine gum, and theophylline disposition. Ann Intern Med 1987; 106: 553-5.
24. Ito K. Lim S. Caramori G. et al. A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression Proc Natl Acad Sci USA 99 2002 8921-8926
25. Shannon M. Predictors of major toxicity after theophylline overdose Ann Intern Med 119 1993 1161-1167
26. Ohta K. Fukuchi Y. Grouse L. et al. Pharmacokinetics and safety of oral theophylline (Theodur®) in the elderly Am J Respir Crit Care Med 157 2001 D31
27. Derby L.E. Jick S.S. Langlois J.C. Johnson L.E. Jick H. Hospital admission for xanthine toxicity Pharmacotherapy 10 1990 112-114
28. Hendeles L. Weinberger M. Szefler S. Ellis E. Safety and efficacy of theophylline in children with asthma J Pediatr 120 1992 177-183
29. Hendeles L. Weinberger M. Bighley L. Disposition of theophylline after a single intravenous infusion of aminophylline Am Rev Respir Dis 118 1978 97-103
30. Weinberger M. Hendeles L. Therapeutic effect and dosing strategies for theophylline in the treatment of chronic asthma J Allergy Clin Immunol 78 1986 762-768